8605 Cameron Street, Suite 400
Silver Spring, MD
USA 20910
Email: tberger@vva.org
Disclosure statement:
Qualified on the content I am responsible for because: Senior Analyst for Veterans Benefits & Mental Health Issues with the Vietnam Veterans of America (VVA) Dr. Tom Berger is a Life Member of Vietnam Veterans of America and currently serves as national chair of VVA’s PTSD and Substance Abuse Committee. As such, he is a member of the Veterans’ Healthcare Administration’s (VHA) Consumer Liaison Council for the Committee on Care of Veterans with Serious Mental Illness. In addition, Dr. Berger holds the distinction of being the first representative of a national veterans’ service organization to hold membership on the Executive Committee of the VHA’s Substance Use Disorder Quality Enhancement Research Initiative. He is also a member of VVA’s Health Care, Government Affairs, and Project 112/SHAD committees. At the local level he serves as Secretary of the Missouri Vietnam Veterans Foundation and as Membership Chair and Assistant Secretary for V.V.A.’s Missouri State Council. Dr. Berger served as a Navy Corpsman with the 3rd Marine Corps Division in Vietnam, 1967-68. Upon completion of his military service and then subsequently after earning his doctoral degree, he held faculty and administrative appointments at the University of Kansas in Lawrence, the State University System of Florida in Tallahassee and the University of Missouri-Columbia, as well as program administrator positions with the Illinois Easter Seal Society and United Cerebral Palsy of Northwest Missouri. His professional publications include books and research articles in the biological sciences, wildlife regulatory law, adolescent risk behaviors, and post-traumatic stress disorder. Dr. Berger now devotes his efforts full-time to veterans’ advocacy at the local, state and national levels on behalf of Vietnam Veterans of America.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.